These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 28829833)

  • 1. Differences of lung microbiome in patients with clinically stable and exacerbated bronchiectasis.
    Byun MK; Chang J; Kim HJ; Jeong SH
    PLoS One; 2017; 12(8):e0183553. PubMed ID: 28829833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel microbiota stratification system predicts future exacerbations in bronchiectasis.
    Rogers GB; Zain NM; Bruce KD; Burr LD; Chen AC; Rivett DW; McGuckin MA; Serisier DJ
    Ann Am Thorac Soc; 2014 May; 11(4):496-503. PubMed ID: 24592925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition.
    Rogers GB; van der Gast CJ; Cuthbertson L; Thomson SK; Bruce KD; Martin ML; Serisier DJ
    Thorax; 2013 Aug; 68(8):731-7. PubMed ID: 23564400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Culture-Independent Analysis of Pediatric Bronchoalveolar Lavage Specimens.
    Zachariah P; Ryan C; Nadimpalli S; Coscia G; Kolb M; Smith H; Foca M; Saiman L; Planet PJ
    Ann Am Thorac Soc; 2018 Sep; 15(9):1047-1056. PubMed ID: 29877714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation.
    Tunney MM; Einarsson GG; Wei L; Drain M; Klem ER; Cardwell C; Ennis M; Boucher RC; Wolfgang MC; Elborn JS
    Am J Respir Crit Care Med; 2013 May; 187(10):1118-26. PubMed ID: 23348972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of Conventional Culture and MALDI-TOF MS for Identification of Microbial Communities in Bronchoalveolar Lavage Fluid in Comparison with the GS Junior Next Generation Sequencing System.
    Sung JY; Hwang Y; Shin MH; Park MS; Lee SH; Yong D; Lee K
    Ann Lab Med; 2018 Mar; 38(2):110-118. PubMed ID: 29214754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study.
    Dicker AJ; Lonergan M; Keir HR; Smith AH; Pollock J; Finch S; Cassidy AJ; Huang JTJ; Chalmers JD
    Lancet Respir Med; 2021 Aug; 9(8):885-896. PubMed ID: 33961805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroid therapy and airflow obstruction influence the bronchial microbiome, which is distinct from that of bronchoalveolar lavage in asthmatic airways.
    Denner DR; Sangwan N; Becker JB; Hogarth DK; Oldham J; Castillo J; Sperling AI; Solway J; Naureckas ET; Gilbert JA; White SR
    J Allergy Clin Immunol; 2016 May; 137(5):1398-1405.e3. PubMed ID: 26627545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals.
    Bassis CM; Erb-Downward JR; Dickson RP; Freeman CM; Schmidt TM; Young VB; Beck JM; Curtis JL; Huffnagle GB
    mBio; 2015 Mar; 6(2):e00037. PubMed ID: 25736890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal assessment of sputum microbiome by sequencing of the 16S rRNA gene in non-cystic fibrosis bronchiectasis patients.
    Cox MJ; Turek EM; Hennessy C; Mirza GK; James PL; Coleman M; Jones A; Wilson R; Bilton D; Cookson WO; Moffatt MF; Loebinger MR
    PLoS One; 2017; 12(2):e0170622. PubMed ID: 28170403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lung microbiome in children with HIV-bronchiectasis: a cross-sectional pilot study.
    Masekela R; Vosloo S; Venter SN; de Beer WZ; Green RJ
    BMC Pulm Med; 2018 May; 18(1):87. PubMed ID: 29788934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Long-Term Erythromycin Therapy on the Oropharyngeal Microbiome and Resistance Gene Reservoir in Non-Cystic Fibrosis Bronchiectasis.
    Choo JM; Abell GCJ; Thomson R; Morgan L; Waterer G; Gordon DL; Taylor SL; Leong LEX; Wesselingh SL; Burr LD; Rogers GB
    mSphere; 2018 Apr; 3(2):. PubMed ID: 29669883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The microbial community of the cystic fibrosis airway is disrupted in early life.
    Renwick J; McNally P; John B; DeSantis T; Linnane B; Murphy P;
    PLoS One; 2014; 9(12):e109798. PubMed ID: 25526264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymicrobial airway bacterial communities in adult bronchiectasis patients.
    Purcell P; Jary H; Perry A; Perry JD; Stewart CJ; Nelson A; Lanyon C; Smith DL; Cummings SP; De Soyza A
    BMC Microbiol; 2014 May; 14():130. PubMed ID: 24886473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct lung microbial community states in patients with pulmonary tuberculosis.
    Hu Y; Kang Y; Liu X; Cheng M; Dong J; Sun L; Zhu Y; Ren X; Yang Q; Chen X; Jin Q; Yang F
    Sci China Life Sci; 2020 Oct; 63(10):1522-1533. PubMed ID: 32303963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering the microbial landscape of lower respiratory tract infections: insights from metagenomics and machine learning.
    Li J; Xiong A; Wang J; Wu X; Bai L; Zhang L; He X; Li G
    Front Cell Infect Microbiol; 2024; 14():1385562. PubMed ID: 38846353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of culture-dependent versus culture-independent techniques for identification of bacteria in clinically obtained bronchoalveolar lavage fluid.
    Dickson RP; Erb-Downward JR; Prescott HC; Martinez FJ; Curtis JL; Lama VN; Huffnagle GB
    J Clin Microbiol; 2014 Oct; 52(10):3605-13. PubMed ID: 25078910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of bronchoscopy and bronchoalveolar lavage findings in three types of suppurative lung disease.
    de Vries JJV; Chang AB; Marchant JM
    Pediatr Pulmonol; 2018 Apr; 53(4):467-474. PubMed ID: 29405664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
    Rogers GB; Bruce KD; Martin ML; Burr LD; Serisier DJ
    Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.
    Mayhew D; Devos N; Lambert C; Brown JR; Clarke SC; Kim VL; Magid-Slav M; Miller BE; Ostridge KK; Patel R; Sathe G; Simola DF; Staples KJ; Sung R; Tal-Singer R; Tuck AC; Van Horn S; Weynants V; Williams NP; Devaster JM; Wilkinson TMA;
    Thorax; 2018 May; 73(5):422-430. PubMed ID: 29386298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.